The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $15.72 in the prior trading day, Beta Bionics Inc (NASDAQ: BBNX) closed at $14.77, down -6.04%. In other words, the price has decreased by -$6.04 from its previous closing price. On the day, 0.58 million shares were traded.
Ratios:
Our goal is to gain a better understanding of BBNX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.93 and its Current Ratio is at 15.88. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on June 16, 2025, initiated with a Buy rating and assigned the stock a target price of $26.
On June 12, 2025, Lake Street started tracking the stock assigning a Buy rating and target price of $30.
On May 30, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $20.Wolfe Research initiated its Outperform rating on May 30, 2025, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’25 when Sean Saint bought 3,439 shares for $17.89 per share.
Hopman Mark sold 868 shares of BBNX for $15,529 on Jun 02 ’25. The Chief Commercial Officer now owns 34,132 shares after completing the transaction at $17.89 per share. On Jun 02 ’25, another insider, Russell Steven Jon, who serves as the Chief Medical Officer of the company, sold 1,039 shares for $17.89 each. As a result, the insider received 18,588 and left with 72,032 shares of the company.
Stock Price History:
Over the past 52 weeks, BBNX has reached a high of $24.50, while it has fallen to a 52-week low of $8.89. The 50-Day Moving Average of the stock is 0.41%, while the 200-Day Moving Average is calculated to be -7.69%.
Shares Statistics:
A total of 43.35M shares are outstanding, with a floating share count of 33.23M. Insiders hold about 23.36% of the company’s shares, while institutions hold 83.50% stake in the company.
